Merck & Co., Inc. Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax
Merck & Co., Inc. (MRK) reported Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax of $446.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-24.
Discontinued › Notes › Equity › Stockholders' Equity Note › AOCI Including Portion Attributable to Noncontrolling Interest
us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax · last filed 2023-02-24
- Merck & Co., Inc. reclassification from accumulated other comprehensive income, current period, before tax for the quarter ending 2015-06-30 was $144.00M.
- Merck & Co., Inc. reclassification from accumulated other comprehensive income, current period, before tax for the quarter ending 2015-03-31 was $173.00M.
- Merck & Co., Inc. reclassification from accumulated other comprehensive income, current period, before tax for the quarter ending 2014-12-31 was $82.00M.
- Merck & Co., Inc. reclassification from accumulated other comprehensive income, current period, before tax for the quarter ending 2014-09-30 was $5.00M.
- Merck & Co., Inc. reclassification from accumulated other comprehensive income, current period, before tax for fiscal 2022 was $446.00M.
- Merck & Co., Inc. reclassification from accumulated other comprehensive income, current period, before tax for fiscal 2021 was -$658.00M.
- Merck & Co., Inc. reclassification from accumulated other comprehensive income, current period, before tax for fiscal 2020 was -$287.00M, a 220.08% decline from fiscal 2019.
- Merck & Co., Inc. reclassification from accumulated other comprehensive income, current period, before tax for fiscal 2019 was $239.00M.
| Period end | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 3 month | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 6 month | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 9 month | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 12 month | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $446.00M 10-K · filed 2023-02-24 | ||||
| 2021-12-31 | -$658.00M 10-K · filed 2023-02-24 | -$473.00M 10-K · filed 2022-02-25 | |||
| 2020-12-31 | -$287.00M 10-K · filed 2023-02-24 | -$253.00M 10-K · filed 2021-02-25 | |||
| 2019-12-31 | $239.00M 10-K · filed 2022-02-25 | ||||
| 2018-12-31 | -$424.00M 10-K · filed 2021-02-25 | ||||
| 2017-12-31 | $315.00M 10-K · filed 2020-02-26 | ||||
| 2015-06-30 | $144.00M 10-Q · filed 2015-08-06 | $317.00M 10-Q · filed 2015-08-06 | $399.00M derived: sum of 3 quarters · filed 2015-08-06 | $404.00M derived: sum of 4 quarters · filed 2015-08-06 | |
| 2015-03-31 | $173.00M 10-Q · filed 2015-05-07 | $255.00M derived: sum of 2 quarters · filed 2015-05-07 | $260.00M derived: sum of 3 quarters · filed 2015-05-07 | $218.00M derived: sum of 4 quarters · filed 2015-08-06 | |
| 2014-12-31 | $82.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $87.00M derived: sum of 2 quarters · filed 2015-02-27 | $45.00M derived: sum of 3 quarters · filed 2015-08-06 | $41.00M 10-K · filed 2015-02-27 | |
| 2014-09-30 | $5.00M 10-Q · filed 2014-11-10 | -$37.00M derived: sum of 2 quarters · filed 2015-08-06 | -$41.00M 10-Q · filed 2014-11-10 | -$125.00M derived: sum of 4 quarters · filed 2015-08-06 | |
| 2014-06-30 | -$42.00M 10-Q · filed 2015-08-06 | -$46.00M 10-Q · filed 2015-08-06 | -$130.00M derived: sum of 3 quarters · filed 2015-08-06 | -$194.00M derived: sum of 4 quarters · filed 2015-08-06 | |
| 2014-03-31 | -$4.00M 10-Q · filed 2015-05-07 | -$88.00M derived: sum of 2 quarters · filed 2015-05-07 | -$152.00M derived: sum of 3 quarters · filed 2015-05-07 | -$217.00M derived: sum of 4 quarters · filed 2015-05-07 | |
| 2013-12-31 | -$84.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$148.00M derived: sum of 2 quarters · filed 2015-02-27 | -$213.00M derived: sum of 3 quarters · filed 2015-02-27 | -$289.00M 10-K · filed 2015-02-27 | |
| 2013-09-30 | -$64.00M 10-Q · filed 2014-11-10 | -$129.00M derived: sum of 2 quarters · filed 2014-11-10 | -$205.00M 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | -$65.00M 10-Q · filed 2014-08-07 | -$141.00M 10-Q · filed 2014-08-07 | |||
| 2013-03-31 | -$76.00M 10-Q · filed 2014-05-08 | ||||
| 2012-12-31 | -$156.00M 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |